After 12.5 mg weekly, the next dose is 15 mg weekly
After completing at least 4 weeks on Mounjaro 12.5 mg weekly, increase to 15 mg weekly if additional glycemic control is needed. 1
Dosing Algorithm
The FDA-approved titration schedule for Mounjaro follows a structured escalation pattern 1:
- Start: 2.5 mg weekly (initiation dose, not for glycemic control)
- Week 4: Increase to 5 mg weekly
- Week 8+: Increase in 2.5 mg increments every 4 weeks as needed:
- 7.5 mg weekly
- 10 mg weekly
- 12.5 mg weekly ← current dose
- 15 mg weekly ← next and maximum dose
The maximum approved dose is 15 mg weekly for adults 1. This represents the final step in the titration sequence.
Clinical Context
The 2025 AACE guidelines confirm that tirzepatide is titrated monthly from 2.5 mg to a maximum of 15 mg weekly 2. The highest dose (15 mg) demonstrated the greatest efficacy in the SURMOUNT-1 trial, producing 22.5% average weight reduction at 72 weeks, with nearly 40% of participants losing ≥25% body weight 2.
Key Considerations
- Timing: Wait at least 4 weeks on 12.5 mg before advancing to 15 mg 1
- Rationale for increase: Only escalate if additional glycemic control is needed 1
- Gastrointestinal tolerance: The gradual monthly titration reduces GI adverse events, which occur most commonly during dose escalation 2
- No further escalation: 15 mg is the ceiling dose—there is no approved dose beyond this for adults 1
Common Pitfall
Do not skip the 4-week minimum interval between dose increases. Rapid escalation increases the risk of nausea, vomiting, and diarrhea, potentially leading to treatment discontinuation 2. The structured titration allows the body time to acclimate to the medication 2.